Studies on miRNA highlight its significance as an immunomarker for several diseases, including tuberculosis. This study aimed to determine the difference between miR-425-5p and miR-4523 expressions in patients with active pulmonary TB (PTB), latent TB infection (LTBI), and lymph node TB (LNTB), whose diagnosis remains challenging. This case–control study was performed on blood samples obtained from 23 patients with PTB, 21 with LTBI, 21 with LNTB, and 25 healthy controls (HC). miRNA hsa-miR-425-5p and hsa-miR-4523 expression levels were measured by RT-qPCR. Statistical analyses were performed using SPSS version 25.0. RT-qPCR showed that hsa-mir-425-5p and hsa-mir-4523 expression levels were significantly different among the four groups (PTB, LTBI, LNTB, and HCs). The hsa-mir-425-5p miRNA expression level in LNTB was higher than that in LTBI (p = 0.003). Meanwhile, the hsa-mir-4523 miRNA expression was downregulated in PTB and LNTB than in LTBI (p < 0.0001 and p = 0.015, respectively). The ROC analysis of a single sample showed that only mir-4523 could discriminate LTBI and HCs, with an AUC of 0.829 (p < 0.001). The ROC curve of each miRNA was further analyzed after logistic regression by adjusting for sex and age. The combination of both miRNAs was also analyzed. The model that analyzed the combination of both miRNAs after adjusting for age had the best performance in differentiating LNTB from LTBI, with an AUC of 0.97 (p < 0.001). miRNA hsa-mir-425-5p was upregulated and miRNA hsa-mir-4523 was downregulated in PTB and LNTB than in LTBI.
1 July 2026 in International Journal of Mycobacteriology
Background: Rapid detection of isoniazid (INH) resistance remains important for tuberculosis management, although targeted molecular assays may not capture the full genetic heterogeneity underlying phenotypic resistance. This study evaluated multiplex allele-specific polymerase chain reaction (MAS-PCR) for detecting INH resistance-associated molecular patterns in Mycobacterium tuberculosis . Methods: This cross-sectional diagnostic accuracy study included 100 sputum specimens, comprising 70 acid-fast bacilli smear-positive and 30 smear-negative specimens. Phenotypic INH susceptibility was determined using Mycobacteria Growth Indicator Tube drug-susceptibility testing (DST-MGIT). MAS-PCR interrogated resistance-associated regions, with particular emphasis on katG315 and ahpC. Diagnostic performance and agreement were assessed in the primary evaluable population of 64 smear-positive specimens with paired MAS-PCR and DST-MGIT results. Results: Among the 64 evaluable specimens, MAS-PCR yielded 5 true-positive, 3 false-negative, 0 false-positive, and 56 true-negative results. Sensitivity was 62.5% (95% confidence interval [CI]: 24.5%–91.5%), specificity of 100.0% (95% CI: 93.6%–100.0%), positive predictive value of 100.0% (95% CI: 47.8%–100.0%), negative predictive value of 94.9% (95% CI: 85.9%–98.9%), and accuracy of 95.3% (95% CI: 86.9%–99.0%). Overall agreement was 95.3%, with substantial agreement beyond chance (Cohen’s κ≈0.745). The exact McNemar’s test showed no evidence of systematic directional discordance ( P = 0.250). The targeted katG315 mutation-associated pattern occurred exclusively among phenotypically resistant specimens, whereas no targeted ahpC pattern was detected. Conclusion: MAS-PCR demonstrated high specificity and substantial agreement with DST-MGIT among evaluable smear-positive specimens but incomplete sensitivity for phenotypic INH resistance. These findings support its use as a complementary targeted molecular approach rather than a replacement for phenotypic DST.